 |
市场调查报告书
商品编码
1873977
3D列印药物市场3D Printed Drugs Market |
||||||
预计3D列印药物市场将从2024年的3,680万美元成长到2031年的8,308万美元，2031年至2031年期间的年复合成长率（CAGR）为9.6%。采用创新技术进行3D药物列印以提高治疗效果的趋势预计将成为市场发展的重要因素。
3D列印药物市场分析
3D列印药物是指利用3D列印技术製造的药品，该技术将数位檔案转化为三维实体。这类药物在个人化医疗领域至关重要，有助于探索客製化的药物释放曲线。这需要一个数位檔案来指定所需的药物释放特性，包括药物浓度、释放速率和动力学、时间依赖性释放曲线以及材料属性。这些进步使得精准给药的个人化医疗成为可能，从而提高疗效、改善患者依从性并最大限度地减少副作用。
3D列印药物市场概览
3D列印药物是指利用3D列印技术生产的药品，该技术能够精确製造复杂的结构并客製化剂量。这种方法具有许多优势，包括个人化医疗、复杂几何形状的製造、快速原型製作、按需生产以及增强药物输送。 Spritam和ZipDose就是3D列印药物的例子。市场扩张的驱动因素包括人们对3D列印技术的认知度不断提高以及3D列印研究的显着进步。然而，非法药物製造的潜在风险可能会在预测期内对市场成长产生负面影响。
战略洞察
3D列印药物市场的驱动因素与机会
吞嚥困难发病率上升将有利于市场
全球人口持续成长，预计到2050年，65岁以上人口将达到20亿，其中85岁以上人口尤为突出。流行病学研究表明，吞嚥困难在老年人和儿童中普遍存在。根据美国疾病管制与预防中心（CDC）的资料显示，美国每年有超过79.5万人发生中风，其中50%的患者伴随吞嚥障碍。此外，多种神经系统疾病也与吞嚥困难有关。 3D列印药物的多孔特性使其能够在口腔内快速崩解，因此非常适合吞嚥困难的患者，从而推动了预测期内的市场成长。
发展中国家的新兴市场
3D列印技术正被应用于包括时尚、建筑和航太在内的各个领域。在医学领域，它主要应用于牙科和组织工程，而其在製药领域的应用则相对较新。许多产业正在利用3D列印的潜力，专家认为，3D列印（3DP）药物将在未来几年改变製药业的格局。精准医疗具有巨大的潜力，可以为每位患者量身订做剂量。众多製药公司体认到，在开发满足特定患者需求的剂型方面，3D列印技术蕴藏着巨大的机会和灵活性。例如，总部位于辛辛那提的Aprecia公司专注于3D列印药品。此外，2020年2月，默克公司和德国施塔恩贝格的AMCM公司宣布合作开发3D列印片剂。预计此类合作将在预测期内为3D列印药物生产商创造丰厚的利润空间。
3D列印药物市场細項分析
对 3D 列印药物市场进行分析的关键细分市场包括类型、应用和最终用户。
- 依树脂类型划分，市场可分为片剂、胶囊、多重药物植入剂、奈米颗粒、溶液和其他剂型。 2023年，片剂占据最大的市场份额，预计在预测期内将保持最高的复合年增长率。
- 从技术类型来看，市场可分为喷墨列印、直接写入、快速剂量列印、热喷墨列印、熔融沈积成型、粉末床列印、立体光刻（SLA）和半固态挤出（SSE）。 2023年，快速剂量列印占据了最大的市场份额。
3D列印药物市场的地理分析
3D列印药物市场的地理分析将市场划分为五个区域：北美、亚太、欧洲、中东和非洲以及南美和中美洲。北美在3D列印药物市场中处于领先地位，这主要得益于政府和私人对医疗基础设施投资的增加、人们对这类药物认知度的提高以及製药行业技术的进步。众多公司正大力投资研发，以透过重大的产品创新和发展来促进市场成长。策略伙伴关係和合作正成为市场拓展的有效途径，能够充分利用各公司多元化的技能和专业知识。例如，研究和医疗实验室公司Organovo正在引领美国3D生物列印领域的研发。此外，该公司于2020年初向美国食品药物管理局（FDA）提交了其生物打印肝组织用于治疗罕见疾病的IND申请。
3D列印药物市场报告范围（请将此关键字保留在此处，以便Shyam查看）
请勿在此处新增任何表格
“
3D列印药物市场的最新发展
对3D列印药物市场的评估是基于从一手和二手研究中获得的定性和定量资料，包括重要的企业出版物、协会资料和资料库。以下是该市场在创新、业务扩张和策略方面的最新发展：
- 2023年10月，芬兰医疗科技公司CurifyLabs宣布推出全球首款符合GMP（药品生产品质管理规范）标准的3D列印药品专用墨水。据该公司称，CurifyLabs的药品工具包包含自动化3D列印技术和可列印药品专用墨水，旨在促进个人化医疗的更广泛应用，从而改善未来不同需求患者的医疗服务。 （资料来源：CurifyLabs，新闻稿）
- 2023年9月，立陶宛健康科学大学（LSMU）推出了首台经认证的製药3D列印机。这项新技术标誌着製药技术创新取得了重大进展，它能够生产针对个别患者的个人化药物，透过将多种成分组合在单片药片中来提高药物疗效，并减少副作用。 （资料来源：立陶宛健康科学大学，新闻稿）
3D列印药物市场报告的覆盖范围和交付成果
这份题为《3D列印药物市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：
- 3D列印药物市场规模及预测，涵盖全球、区域和国家层面的所有关键细分市场。
- 市场动态，例如驱动因素、限制因素和关键机会
- 3D列印药物市场趋势
- 详细的PEST和SWOT分析
- 对 3D 列印药物市场进行分析，涵盖关键趋势、全球和区域框架、主要参与者、法规和近期市场发展。
- 3D列印药物市场的产业格局和竞争分析，包括市场集中度、热图分析、主要参与者和最新发展。
- 深入的公司概况。
目录
第一章：引言
第二章：3D列印药物市场及主要结论
第三章：研究方法
- 覆盖范围
- 二手研究
- 初步研究
第四章：全球3D列印药物市场及市场概况
- 概述
- 害虫分析
- 北美和PEST分析
- 欧洲和PEST分析
- 亚太地区及PEST分析
- 中东和非洲以及 PEST 分析
- 南美洲和中美洲以及 PEST 分析
第五章：全球3D列印药物市场及主要市场动态
- 市场驱动因素
- 个人化药物应用日益普及
- 吞嚥困难盛行率不断上升
- 市场限制
- 利用3D列印技术製造非法毒品
- 市场机会
- 人们对3D列印技术的认识不断提高
- 未来趋势
- 采用新技术进行3D药物列印，以简化流程并取得良好效果
- 影响分析
第六章：3D列印药物市场及全球分析
- 全球3D列印药物市场收入预测与分析
- 全球3D列印药物市场（依地理划分）－预测与分析
- 关键参与者的市场定位
第七章：3D列印药物市场分析及剂型分析
- 概述
- 2024 年及 2031 年 3D 列印药物市占率（以剂型划分，%）
- 片剂
- 胶囊
- 多重植入物
- 奈米颗粒
- 解决方案
- 其他剂型
第八章：3D列印药物市场分析及技术分类
- 概述
- 按技术分類的3D列印药物市场份额，2024年和2031年（%）
- 喷墨列印
- 直接写入
- Zip Dose
- 热喷墨列印
- 熔融沈积成型
- 粉末床列印
- 立体光刻（SLA）
- 半固态挤出（SSE）
第九章：3D列印药物市场及地理分析
- 北美洲
- 我们
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 亚太地区
- 中国
- 日本
- 印度
- 韩国
- 澳洲
- 中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 南美洲和中美洲
- 巴西
- 阿根廷
第十章：新冠肺炎疫情对全球罕见神经系统疾病治疗市场的影响
- 北美洲
- 欧洲
- 亚太
- 世界其他地区
第十一章：3D列印药物市场与产业概况
- 概述
- 市场中各公司采取的成长策略（%）
- 有机发展
- 概述
- 无机物发展
- 概述
第十二章：公司简介
- GlaxoSmithKline plc.
- Aprecia Pharmaceuticals, LLC.
- AstraZeneca
- FabRx Ltd
- Merck KGaA
- Cycle Pharmaceuticals
- Tvasta
- MSD
第十三章：附录
The 3D Printed Drugs Market is anticipated to grow from US$ 36.80 million in 2024 to US$ 83.08 million by 2031, reflecting a compound annual growth rate (CAGR) of 9.6% during the period from 2031 to 2031. The trend towards adopting innovative technologies in 3D drug printing to enhance procedural outcomes is expected to be a significant factor in the market's development.
Analysis of the 3D Printed Drugs Market
A 3D printed drug is a pharmaceutical product created through 3D printing technology, which transforms a digital file into a three-dimensional solid. These drugs are crucial in the realm of personalized medicine, facilitating the exploration of customized drug release profiles. This involves a digital file that specifies the desired drug release characteristics, including drug concentration, release rate and kinetics, time-dependent release profile, and material properties. Such advancements enable the creation of personalized medicine with accurate drug delivery, leading to enhanced efficacy, improved patient adherence, and minimized side effects.
Overview of the 3D Printed Drugs Market
3D printed drugs are pharmaceuticals produced using 3D printing technology, which allows for the precise creation of intricate structures and tailored dosages. This method provides numerous advantages, including personalized medicine, complex geometries, rapid prototyping, on-demand production, and enhanced drug delivery. Examples of 3D-printed drugs include Spritam and ZipDose. The market's expansion is driven by factors such as increasing awareness of 3D printing and significant advancements in 3D printing research. However, the potential for illegal drug manufacturing may negatively impact market growth during the forecast period.
Strategic Insights
Drivers and Opportunities in the 3D Printed Drugs Market
Rising Incidence of Dysphagia to Benefit the Market
The global population is on the rise, with projections indicating that by 2050, there will be 2 billion individuals aged 65 and older, particularly among those over 85. Epidemiological studies show that dysphagia is prevalent in older adults and children. According to CDC data, over 795,000 individuals in the US suffer strokes annually, with 50% experiencing swallowing disorders. Additionally, various neurological conditions are linked to dysphagia. The porous nature of 3D-printed drugs allows them to disintegrate easily in the mouth, making them suitable for patients with swallowing difficulties, thus propelling market growth during the forecast period.
Emerging Markets in Developing Nations
3D printing technologies are being utilized across various sectors, including fashion, construction, and aerospace. In medicine, they are primarily applied in dentistry and tissue engineering, while their use in pharmaceuticals is relatively new. Many industries are harnessing the potential of 3D printing, and experts believe that 3D printed (3DP) medications will transform the pharmaceutical landscape in the coming years. There is significant potential for precision medicine to customize dosages for individual patients. Numerous pharmaceutical companies recognize the vast opportunities and flexibility in creating dosage forms tailored to specific patient requirements. For example, Aprecia, based in Cincinnati, specializes in 3DP medicinal products. Furthermore, in February 2020, Merck and AMCM from Starnberg, Germany, announced a partnership to develop 3D printed tablets. Such initiatives are expected to create lucrative opportunities for manufacturers of 3D-printed drugs in the forecast period.
Segmentation Analysis of the 3D Printed Drugs Market
Key segments contributing to the analysis of the 3D printed drugs market include type, application, and end user.
- By resin type, the market is categorized into tablets, capsules, multi-drug implants, nanoparticles, solutions, and other dosage forms. The tablet segment accounted for the largest market share in 2023 and is projected to exhibit the highest CAGR during the forecast period.
- In terms of technology type, the market is divided into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi-solid extrusion (SSE). The zip dose segment held the largest market share in 2023.
Geographical Analysis of the 3D Printed Drugs Market
The geographical analysis of the 3D printed drugs market is segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. North America leads the 3D printed drugs market, driven by increased government and private investment in healthcare infrastructure, heightened awareness of these drugs, and advancements in technology within the pharmaceutical sector. Numerous companies are investing heavily in R&D to foster market growth through significant product innovations and developments. The market is witnessing strategic partnerships and collaborations as a promising avenue for expanding market presence by leveraging the diverse skills and expertise of various companies. For instance, Organovo, a research and medical laboratory firm, is pioneering R&D in 3D bioprinting in the country. Additionally, the company approached the FDA in early 2020 with an IND application for its bio-printed liver tissue aimed at treating rare diseases.
Scope of the 3D Printed Drugs Market Report (KEEP THIS KEYWORD HERE FOR SHYAM)
“DO NOT ADD ANY TABLE HERE
”
Recent Developments in the 3D Printed Drugs Market
The evaluation of the 3D printed drugs market is based on qualitative and quantitative data obtained from primary and secondary research, including significant corporate publications, association data, and databases. Below are recent developments in the market regarding innovations, business expansions, and strategies:
- In October 2023, Finnish healthtech company CurifyLabs announced the launch of the world's first GMP (good manufacturing practice) produced Pharma Inks for 3D printable medicines. CurifyLabs' Pharma Kit, which includes automated 3D printing technology and printable pharmaceutical inks, aims to facilitate the broader adoption of personalized medicine, enhancing future care for patients with diverse needs, according to the company. (Source: CurifyLabs, Press Release)
- In September 2023, LSMU (Lithuanian University of Health Sciences) introduced the first validated pharmaceutical 3D printer. This new device marks a significant advancement in pharmaceutical technology innovation, enabling the production of personalized medicine tailored to individual patients, improving drug efficacy by combining multiple substances in a single tablet, and reducing side effects. (Source: LSMU, Press Release)
Coverage and Deliverables of the 3D Printed Drugs Market Report
The report titled "3D Printed Drugs Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:
- 3D Printed Drugs Market size and forecast at global, regional, and country levels for all key market segments included in the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Trends in the 3D Printed Drugs Market
- Detailed PEST and SWOT analysis
- Analysis of the 3D Printed Drugs Market covering key trends, global and regional frameworks, major players, regulations, and recent market developments.
- Industry landscape and competition analysis of the 3D Printed Drugs Market, including market concentration, heat map analysis, prominent players, and recent developments.
- In-depth company profiles.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global 3D Printed Drugs Market and By Dosage Forms
- 1.3.2 Global 3D Printed Drugs Market and By Technology
- 1.3.3 Global 3D Printed Drugs Market and By Geography
2. 3D Printed Drugs Market and Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Global 3D Printed Drugs Market and Market Landscape
- 4.1 Overview
- 4.2 Pest Analysis
- 4.2.1 North America and PEST Analysis
- 4.2.2 Europe and PEST Analysis
- 4.2.3 Asia Pacific and PEST Analysis
- 4.2.4 Middle East and Africa and PEST Analysis
- 4.2.5 South and Central America and PEST Analysis
5. Global 3D Printed Drugs market and Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Adoption of Personalized Drugs
- 5.1.2 Increasing Prevalence of Dysphagia
- 5.2 Market Restraints
- 5.2.1 Usage of 3D Printing to Develop Illegal Drugs
- 5.3 Market Opportunities
- 5.3.1 Rising Awareness About the 3D Printing Technology
- 5.4 Future Trends
- 5.4.1 Adoption of Novel Technologies in 3D Drugs Printing to Streamline Procedural Outcomes
- 5.5 Impact analysis
6. 3D Printed Drugs Marketand Global Analysis
- 6.1 Global 3D Printed Drugs Market Revenue Forecast And Analysis
- 6.2 Global 3D Printed Drugs Market, By Geography - Forecast And Analysis
- 6.3 Market Positioning of Key Players
7. 3D Printed Drugs Market Analysis and By Dosage Forms
- 7.1 Overview
- 7.2 3D Printed Drugs Market Share, by Dosage Forms, 2024 and 2031, (%)
- 7.3 Tablets
- 7.3.1 Overview
- 7.3.2 Tablets: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.3.3 Tablets: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.4 Capsules
- 7.4.1 Overview
- 7.4.2 Capsules: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.5 Multi Drug Implant
- 7.5.1 Overview
- 7.5.2 Multi Drug Implant: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.6 Nanoparticles
- 7.6.1 Overview
- 7.6.2 Nanoparticles: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.7 Solutions
- 7.7.1 Overview
- 7.7.2 Solutions: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.8 Other Dosage Forms
- 7.8.1 Overview
- 7.8.2 Other Dosage Forms: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
8. 3D Printed Drugs Market Analysis and By Technology
- 8.1 Overview
- 8.2 3D Printed Drugs Market Share, by Technology, 2024 and 2031 (%)
- 8.3 Inkjet Printing
- 8.3.1 Overview
- 8.3.2 Inkjet Printing: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.4 Direct Write
- 8.4.1 Overview
- 8.4.2 Direct Write: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.5 Zip Dose
- 8.5.1 Overview
- 8.5.2 Zip Dose: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.5.3 Zip Dose: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.6 Thermal Inkjet Printing
- 8.6.1 Overview
- 8.6.2 Thermal Inkjet: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.7 Fused Deposition Modelling
- 8.7.1 Overview
- 8.7.2 Fused Deposition Modelling: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 8.8 Powder Bed Printing
- 8.8.1 Overview
- 8.8.2 Powder Bed Printing: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 8.9 Stereolithography (SLA)
- 8.9.1 Overview
- 8.9.2 Stereolithography (SLA): 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 8.10 Semi Solid Extrusion (SSE)
- 8.10.1 Overview
- 8.10.2 Semi Solid Extrusion (SSE): 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
9. 3D Printed Drugs Market and Geographic Analysis
- 9.1 North America: 3D Printed Drugs Market
- 9.1.1 Overview
- 9.1.2 North America: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.3 North America: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.4 North America: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.5 North America: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.6 North America: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.7 North America: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.8 North America: 3D Printed Drugs Market, by Country, 2031 and 2031 (%)
- 9.1.9 US: 3D Printed Drugs Market and Revenue and Forecast (USD thousands)
- 9.1.9.1 US: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.9.2 US: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.9.3 US: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.9.4 US: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.9.5 US: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.9.6 US: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.10 Canada: 3D Printed Drugs Market and Revenue and Forecast (USD Thousands)
- 9.1.10.1 Canada: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.10.2 Canada: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.10.3 Canada: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.11 Mexico: 3D Printed Drugs Market and Revenue and Forecast (USD thousands)
- 9.1.11.1 Mexico: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.11.2 Mexico: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.11.3 Mexico: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2 Europe: 3D Printed Drugs Market
- 9.2.1 Overview
- 9.2.2 Europe: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.3 Europe: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.4 Europe: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.5 Europe: 3D Printed Drugs Market, by Country, 2024 and 2031 (%)
- 9.2.6 Germany: 3D Printed Drugs Market
- 9.2.6.1 Germany: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.6.2 Germany: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.6.3 Germany: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.7 United Kingdom: 3D Printed Drugs Market
- 9.2.7.1 United Kingdom: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.7.2 United Kingdom: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.7.3 United Kingdom: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.8 France: 3D Printed Drugs Market
- 9.2.8.1 France: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.8.2 France: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.8.3 France: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.9 Italy: 3D Printed Drugs Market
- 9.2.9.1 Italy: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.9.2 Italy: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.9.3 Italy: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.10 Spain: 3D Printed Drugs Market
- 9.2.10.1 Spain: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.10.2 Spain: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.10.3 Spain: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3 Asia Pacific: 3D Printed Drugs Market
- 9.3.1 Overview
- 9.3.2 Asia Pacific: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.3 Asia Pacific: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.4 Asia Pacific: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.5 Asia Pacific: 3D Printed Drugs Market, by Country, 2024 and 2031 (%)
- 9.3.6 China: 3D Printed Drugs Market
- 9.3.6.1 China: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.6.2 China: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.6.3 China: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.7 Japan: 3D Printed Drugs Market
- 9.3.7.1 Japan: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.7.2 Japan: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.7.3 Japan: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.8 India: 3D Printed Drugs Market
- 9.3.8.1 India: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.8.2 India: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.8.3 India: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.9 South Korea: 3D Printed Drugs Market
- 9.3.9.1 South Korea: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.9.2 South Korea: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.9.3 South Korea: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.10 Australia: 3D Printed Drugs Market
- 9.3.10.1 Australia: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.10.2 Australia: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.10.3 Australia: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.4 Middle East and Africa: 3D Printed Drugs Market
- 9.4.1 Overview
- 9.4.2 Middle East and Africa: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.4.3 Middle East and Africa: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.4.4 Middle East and Africa: 3D Printed Drugs Market, by Country, 2024 and 2031 (%)
- 9.4.5 Saudi Arabia: 3D Printed Drugs Market
- 9.4.5.1 Saudi Arabia: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.4.5.2 Saudi Arabia: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.4.5.3 Saudi Arabia: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.4.6 South Africa: 3D Printed Drugs Market
- 9.4.6.1 South Africa: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.4.6.2 South Africa: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.4.6.3 South Africa: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.4.7 UAE: 3D Printed Drugs Market
- 9.4.7.1 UAE: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.4.7.2 UAE: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.4.7.3 UAE: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.5 South and Central America: 3D Printed Drugs Market
- 9.5.1 Overview
- 9.5.2 South and Central America: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.5.3 South and Central America: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.5.4 South and Central America: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.5.5 South and Central America: 3D Printed Drugs Market, by Country, 2024 and 2031 (%)
- 9.5.6 Brazil: 3D Printed Drugs Market
- 9.5.6.1 Brazil: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.5.6.2 Brazil: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.5.6.3 Brazil: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.5.7 Argentina: 3D Printed Drugs Market
- 9.5.7.1 Argentina: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.5.7.2 Argentina: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.5.7.3 Argentina: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
10. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market
- 10.1 North America: Impact Assessment of COVID-19 Pandemic
- 10.2 Europe: Impact assessment of COVID-19 Pandemic
- 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
- 10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. 3D Printed Drugs Market andIndustry Landscape
- 11.1 Overview
- 11.2 Growth Strategies Done by the Companies in the Market, (%)
- 11.3 Organic Developments
- 11.3.1 Overview
- 11.4 Inorganic Developments
- 11.4.1 Overview
12. Company Profiles
- 12.1 GlaxoSmithKline plc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Aprecia Pharmaceuticals, LLC.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 AstraZeneca
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 Key Developments
- 12.4 FabRx Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Merck KGaA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Cycle Pharmaceuticals
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Tvasta
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 MSD
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
